fine mapping qtls using recombinant-inbred hs and in-vitro hs william valdar jonathan flint, richard...

28
Fine mapping QTLs using Recombinant-Inbred HS and In-Vitro HS William Valdar Jonathan Flint, Richard Mott Wellcome Trust Centre for Human Genetics

Upload: allen-williams

Post on 12-Jan-2016

224 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Fine mapping QTLs using Recombinant-Inbred HS and In-Vitro HS William Valdar Jonathan Flint, Richard Mott Wellcome Trust Centre for Human Genetics

Fine mapping QTLs using Recombinant-Inbred HS

and In-Vitro HS

William Valdar

Jonathan Flint, Richard Mott

Wellcome Trust Centre for Human Genetics

Page 2: Fine mapping QTLs using Recombinant-Inbred HS and In-Vitro HS William Valdar Jonathan Flint, Richard Mott Wellcome Trust Centre for Human Genetics

Heterogeneous Stocks

Pseudo-random matingfor N generations

typicalchromosome

pair

8 inbred lines

eg, N=30:3.4cM (=100/30)average distance

between recombinants

Page 3: Fine mapping QTLs using Recombinant-Inbred HS and In-Vitro HS William Valdar Jonathan Flint, Richard Mott Wellcome Trust Centre for Human Genetics

Cost of mapping with HS• Need to genotype markers at very high density (sub centimorgan)

• Expensive to genotype whole genome (eg 3000 markers for 30 generation HS)

• How can we reduce genotyping cost ?• Use multiple phenotypes (value for money)

Two genetic strategies:• RIHS Recombinant Inbred Heterogeneous Stock• IVHS In vitro Heterogeneous Stock

Page 4: Fine mapping QTLs using Recombinant-Inbred HS and In-Vitro HS William Valdar Jonathan Flint, Richard Mott Wellcome Trust Centre for Human Genetics

Recombinant Inbred HS (RIHS)

X20

generations

HS HS RIHS

Page 5: Fine mapping QTLs using Recombinant-Inbred HS and In-Vitro HS William Valdar Jonathan Flint, Richard Mott Wellcome Trust Centre for Human Genetics

Recombinant Inbred HS (RIHS)

X20

generations

HS HS RIHS

• Genotype each RIHS line once

• Keep stock, eg, as embryos

• Distribute RIHS lines to labs for phenotyping

Page 6: Fine mapping QTLs using Recombinant-Inbred HS and In-Vitro HS William Valdar Jonathan Flint, Richard Mott Wellcome Trust Centre for Human Genetics

Recombinant Inbred HS (RIHS)

X20

generations

HS HS RIHS

Advantage over standard RI : resolutionAdvantage over standard HS: cost

• Genotype each RIHS line once

• Keep stock, eg, as embryos

• Distribute RIHS lines to labs for phenotyping

Page 7: Fine mapping QTLs using Recombinant-Inbred HS and In-Vitro HS William Valdar Jonathan Flint, Richard Mott Wellcome Trust Centre for Human Genetics

RIHS for mapping modifier QTL

X20

generations

X

HS HS RIHS inbred F1

(may containknockout

ortransgene)

modifier search

Page 8: Fine mapping QTLs using Recombinant-Inbred HS and In-Vitro HS William Valdar Jonathan Flint, Richard Mott Wellcome Trust Centre for Human Genetics

• How many RIHS do we need for effective fine-mapping?

• Are there other HS strategies to reduce genotyping…?

Page 9: Fine mapping QTLs using Recombinant-Inbred HS and In-Vitro HS William Valdar Jonathan Flint, Richard Mott Wellcome Trust Centre for Human Genetics

In Vitro HS (IVHS)

HS donor

recombinant

HS sperm F1

IVF

Fertilizeinbred dam

withHS sperm

meiosis

Page 10: Fine mapping QTLs using Recombinant-Inbred HS and In-Vitro HS William Valdar Jonathan Flint, Richard Mott Wellcome Trust Centre for Human Genetics

IVHS-1

genotypedonors at

high resolution

HS donor

recombinant

HS sperm F1

IVF

meiosis

Page 11: Fine mapping QTLs using Recombinant-Inbred HS and In-Vitro HS William Valdar Jonathan Flint, Richard Mott Wellcome Trust Centre for Human Genetics

IVHS-1

genotypedonors at

high resolution

HS donor

recombinant

HS sperm F1

IVF

pass1

pass2

F1 markers

meiosis

Page 12: Fine mapping QTLs using Recombinant-Inbred HS and In-Vitro HS William Valdar Jonathan Flint, Richard Mott Wellcome Trust Centre for Human Genetics

IVHS-2

HS donor

recombinant

HS sperm F1

IVF

treat as average of donor chromosomes

no furthergenotyping

meiosis

genotypedonors at

high resolution

Page 13: Fine mapping QTLs using Recombinant-Inbred HS and In-Vitro HS William Valdar Jonathan Flint, Richard Mott Wellcome Trust Centre for Human Genetics

Simulations• Compare strategies RIHS, IVHS-1, IVHS-2 by simulation

Page 14: Fine mapping QTLs using Recombinant-Inbred HS and In-Vitro HS William Valdar Jonathan Flint, Richard Mott Wellcome Trust Centre for Human Genetics

Simulations• Compare strategies RIHS, IVHS-1, IVHS-2 by simulation• Simulate 25cM chromosome with single additive QTL placed

randomly

Page 15: Fine mapping QTLs using Recombinant-Inbred HS and In-Vitro HS William Valdar Jonathan Flint, Richard Mott Wellcome Trust Centre for Human Genetics

Simulations• Compare strategies RIHS, IVHS-1, IVHS-2 by simulation• Simulate 25cM chromosome with single additive QTL placed

randomly• Type 100 SNP markers

Page 16: Fine mapping QTLs using Recombinant-Inbred HS and In-Vitro HS William Valdar Jonathan Flint, Richard Mott Wellcome Trust Centre for Human Genetics

Simulations• Compare strategies RIHS, IVHS-1, IVHS-2 by simulation• Simulate 25cM chromosome with single additive QTL placed

randomly• Type 100 SNP markers• 30 generation HS

Page 17: Fine mapping QTLs using Recombinant-Inbred HS and In-Vitro HS William Valdar Jonathan Flint, Richard Mott Wellcome Trust Centre for Human Genetics

Simulations• Compare strategies RIHS, IVHS-1, IVHS-2 by simulation• Simulate 25cM chromosome with single additive QTL placed

randomly• Type 100 SNP markers• 30 generation HS• Vary

– QTL effect size (1% to 50%)– # RIHS lines used (40, 80, 120)– Sample size (400 to 2000 total number of pups)

Page 18: Fine mapping QTLs using Recombinant-Inbred HS and In-Vitro HS William Valdar Jonathan Flint, Richard Mott Wellcome Trust Centre for Human Genetics

Simulations• Compare strategies RIHS, IVHS-1, IVHS-2 by simulation• Simulate 25cM chromosome with single additive QTL placed

randomly• Type 100 SNP markers• 30 generation HS• Vary

– QTL effect size (1% to 50%)– # RIHS lines used (40, 80, 120)– Sample size (400 to 2000 total number of pups)

• Also investigate for IVHS-1– Marker density– SNPs v Microsatellites– # HS generations

Page 19: Fine mapping QTLs using Recombinant-Inbred HS and In-Vitro HS William Valdar Jonathan Flint, Richard Mott Wellcome Trust Centre for Human Genetics

Evaluating the simulations• Evaluation

– Perform 1000 simulations per condition– Analysis performed with HAPPY– Probability of detecting a QTL (must be a marker interval with

adjusted HAPPY Pvalue < 1%)– Mapping accuracy

Page 20: Fine mapping QTLs using Recombinant-Inbred HS and In-Vitro HS William Valdar Jonathan Flint, Richard Mott Wellcome Trust Centre for Human Genetics

Detecting a significant locus• Pass rate = % times most significant marker interval has (corrected)

P-value less than 0.01

Page 21: Fine mapping QTLs using Recombinant-Inbred HS and In-Vitro HS William Valdar Jonathan Flint, Richard Mott Wellcome Trust Centre for Human Genetics

Detecting a significant locus• Pass rate = % times most significant marker interval has a corrected

P-value less than 0.01

consistent across population sizes

5%

Page 22: Fine mapping QTLs using Recombinant-Inbred HS and In-Vitro HS William Valdar Jonathan Flint, Richard Mott Wellcome Trust Centre for Human Genetics

Mapping accuracy for significant loci• Mean mapping error = average distance between true QTL and the

predicted locus

mapping error (cM)predicted QTL true QTL

Page 23: Fine mapping QTLs using Recombinant-Inbred HS and In-Vitro HS William Valdar Jonathan Flint, Richard Mott Wellcome Trust Centre for Human Genetics

Mapping accuracy for significant loci• Mean mapping error = average distance between true QTL and the

predicted locus

mapping error (cM)predicted QTL true QTL

Page 24: Fine mapping QTLs using Recombinant-Inbred HS and In-Vitro HS William Valdar Jonathan Flint, Richard Mott Wellcome Trust Centre for Human Genetics

Varying marker density and marker type• IVHS-1 strategy with 5%QTL, 1200 pups• Vary number of markers over a 3cM region

Page 25: Fine mapping QTLs using Recombinant-Inbred HS and In-Vitro HS William Valdar Jonathan Flint, Richard Mott Wellcome Trust Centre for Human Genetics

Varying marker density and marker type• IVHS-1 strategy with 5%QTL, 1200 pups• Vary number of markers over a 3cM region

Microsats betterMicrosats = SNPs

~0.05cM

Page 26: Fine mapping QTLs using Recombinant-Inbred HS and In-Vitro HS William Valdar Jonathan Flint, Richard Mott Wellcome Trust Centre for Human Genetics

Varying number of HS generations• IVHS-1 strategy with 5%QTL, 1200 pups

Page 27: Fine mapping QTLs using Recombinant-Inbred HS and In-Vitro HS William Valdar Jonathan Flint, Richard Mott Wellcome Trust Centre for Human Genetics

Varying number of HS generations• IVHS-1 strategy with 5%QTL, 1200 pups

optimum [5,15]

Page 28: Fine mapping QTLs using Recombinant-Inbred HS and In-Vitro HS William Valdar Jonathan Flint, Richard Mott Wellcome Trust Centre for Human Genetics

Conclusions• RIHS and IVHS strategies: low genotyping cost without sacrificing

mapping resolution

• IVHS is short term mapping strategy

• RIHS takes longer, costs more but is long term strategy of choice.

• 100 RIHS lines is sufficient for mapping isolated additive QTLs but may not be enough for

• multiple QTLs • identifying epistatic effects

• Suitable HS: need only 15 generations

Paper submitted to Mammalian Genome (preprints available)